Tanja Tomic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tanja Tomic has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Martin Charles Henman
Trinity College Dublin, Dublin, Ireland
2 shared publications - Milena Santric-Milicevic
Institute of Social Medicine, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
2 shared publications Dragana Lakic
Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
1 shared publicationIvana Tadic
Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
1 shared publication- Ivana Tadic
Department of Clinical Pharmacy, Innsbruck University
1 shared publication - Ivona Ljevak
Faculty of Health Studies, University of Mostar, 88000 Mostar, Bosnia and Herzegovina
1 shared publication
Latest Publications
- Open Access
- 30 April 2024
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 18 (04) , 504-512
Immediate and long-term effects of COVID-19 on antibiotic dispensing: increasing use of Watch antibiotics
Introduction: The coronavirus disease 2019 (COVID-19) pandemic affected antibiotic usage worldwide. However, there is limited data from Serbia. Dispensing of oral antibiotics in Serbian pharmacies was analyzed to calculate monthly and yearly changes between 2018-2021, and to explore immediate and long-term effects of COVID-19 on antibiotic dispensing during this period. Methodology: The number of antibiotic packages dispensed from pharmacies during the study period was analyzed with a Chi-square test to assess the average change in annual dispensing, and an interrupted time-series analysis was used to evaluate the impact of the pandemic on antibiotic dispensing. The data from 2018-2021 were retrieved from the database of a large community pharmacy chain in Serbia. Results: The average number of antibiotic packages dispensed per day and per pharmacy was higher in 2021 compared to 2018 by one package. However, the dispensing of macrolides increased significantly; 17.7% (2018) vs. 22.5% (2021) (p < 0.05). In general, an increase in antibiotic dispensing was detected during COVID-19 for total antibiotics (16.4%), Watch antibiotics (44.8%), third-generation cephalosporins (80.4%), macrolides (45.5%) and azithromycin (83.7%). However, the immediate effect of COVID-19 was a decrease in the dispensing of Watch antibiotics, penicillin, and third-generation cephalosporins (p < 0.05); and a notable long-term COVID-19 effect was an increase in the dispensing of azithromycin (p < 0.05). Conclusions: In spite of a relatively stable trend of total antibiotic dispensing before and during COVID-19 pandemic, the use of Watch antibiotics, third-generation cephalosporins, and macrolides (particularly azithromycin) showed an increasing trend in dispensing that should be optimized.
- 30 April 2024
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 18 (04) , 504-512
Open AccessImmediate and long-term effects of COVID-19 on antibiotic dispensing: increasing use of Watch antibiotics
Introduction: The coronavirus disease 2019 (COVID-19) pandemic affected antibiotic usage worldwide. However, there is limited data from Serbia. Dispensing of oral antibiotics in Serbian pharmacies was analyzed to calculate monthly and yearly changes between 2018-2021, and to explore immediate and long-term effects of COVID-19 on antibiotic dispensing during this period. Methodology: The number of antibiotic packages dispensed from pharmacies during the study period was analyzed with a Chi-square test to assess the average change in annual dispensing, and an interrupted time-series analysis was used to evaluate the impact of the pandemic on antibiotic dispensing. The data from 2018-2021 were retrieved from the database of a large community pharmacy chain in Serbia. Results: The average number of antibiotic packages dispensed per day and per pharmacy was higher in 2021 compared to 2018 by one package. However, the dispensing of macrolides increased significantly; 17.7% (2018) vs. 22.5% (2021) (p < 0.05). In general, an increase in antibiotic dispensing was detected during COVID-19 for total antibiotics (16.4%), Watch antibiotics (44.8%), third-generation cephalosporins (80.4%), macrolides (45.5%) and azithromycin (83.7%). However, the immediate effect of COVID-19 was a decrease in the dispensing of Watch antibiotics, penicillin, and third-generation cephalosporins (p < 0.05); and a notable long-term COVID-19 effect was an increase in the dispensing of azithromycin (p < 0.05). Conclusions: In spite of a relatively stable trend of total antibiotic dispensing before and during COVID-19 pandemic, the use of Watch antibiotics, third-generation cephalosporins, and macrolides (particularly azithromycin) showed an increasing trend in dispensing that should be optimized.
- 1 December 2023
- Published by University of Sarajevo Faculty of Health Sciences in Kongres "Dani zdravstvenih nauka"-Zbornik sažetaka
SESTRINSKA PROFESIJA IZ PERSPEKTIVE STUDENATA FAKULTETA ZDRAVSTVENIH STUDIJA SVEUČILIŠTA U MOSTARU
Ivona Ljevak*1,Tanja Tomić 1 1 Fakultet zdravstvenih studija Sveučilišta u Mostaru, *Dopisni autor: Ivona Ljevak, Fakultet zdravstvenih studija Sveučilišta u Mostaru, Mostar Bosna i Hercegovina, email: ivona.ljevak@fzs.sum.ba DOI: https://doi.org/10.17532/dzn.2023.005 Sažetak Počeci profesionalnog razvoja sestrinstva datiraju od kraja 19. stoljeća osnivanjem prvih škola za medicinske sestre. Na razvoj sestrinstva tijekom povijesti utjecala su razna zbivanja u svijetu, od društvenih,
- 1 December 2023
- Published by University of Sarajevo Faculty of Health Sciences in Kongres "Dani zdravstvenih nauka"-Zbornik sažetaka
SESTRINSKA PROFESIJA IZ PERSPEKTIVE STUDENATA FAKULTETA ZDRAVSTVENIH STUDIJA SVEUČILIŠTA U MOSTARU
Ivona Ljevak*1,Tanja Tomić 1 1 Fakultet zdravstvenih studija Sveučilišta u Mostaru, *Dopisni autor: Ivona Ljevak, Fakultet zdravstvenih studija Sveučilišta u Mostaru, Mostar Bosna i Hercegovina, email: ivona.ljevak@fzs.sum.ba DOI: https://doi.org/10.17532/dzn.2023.005 Sažetak Počeci profesionalnog razvoja sestrinstva datiraju od kraja 19. stoljeća osnivanjem prvih škola za medicinske sestre. Na razvoj sestrinstva tijekom povijesti utjecala su razna zbivanja u svijetu, od društvenih,
- 7 June 2023
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 45 (4) , 989-998
Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries
Background In Europe, Serbia occupies a high position in antibiotic utilization and antimicrobial resistance (AMR). Aim The aim was to analyse utilization trends of meropenem, ceftazidime, aminoglycosides, piperacillin/tazobactam and fluoroquinolones (2006–2020), and the reported AMR in Pseudomonas aeruginosa (2013–2020) in Serbia and to compare with data from eight European countries (2015–2020). Method Joinpoint regression was used to analyse antibiotic utilization data (2006–2020) and the reported AMR in Pseudomonas aeruginosa (2013–2020). Data sources were relevant national and international institutions. Antibiotic utilization and AMR in Pseudomonas aeruginosa data in Serbia were compared with eight European countries. Results There was a significantly increased trend for ceftazidime utilization and reported resistance in Pseudomonas aeruginosa, Serbia (p < 0.05) (2018–2020). For ceftazidime, piperacillin/tazobactam, and fluoroquinolones resistances in Pseudomonas aeruginosa an increased trend was observed, Serbia (2013–2020). A decrease in both the utilization of aminoglycosides, Serbia (p < 0.05) (2006–2018) and contemporaneous Pseudomonas aeruginosa resistance (p > 0.05) was detected. Fluoroquinolone utilization (2015–2020) was highest in Serbia compared to Netherlands and Finland, 310 and 305% higher, similar compared to Romania, and 2% less compared to Montenegro. Aminoglycosides (2015–2020) were 2550 and 783% more used in Serbia compared to Finland and Netherlands, and 38% less regarding Montenegro. The highest percentage of Pseudomonas aeruginosa resistance was in Romania and Serbia (2015–2020). Conclusion The use of piperacillin/tazobactam, ceftazidime and fluoroquinolones should be carefully monitored in clinical practice due to increased Pseudomonas aeruginosa resistance. The level of utilization and AMR in Pseudomonas aeruginosa is still high in Serbia compared to other European countries.
- 7 June 2023
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 45 (4) , 989-998
Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries
Background In Europe, Serbia occupies a high position in antibiotic utilization and antimicrobial resistance (AMR). Aim The aim was to analyse utilization trends of meropenem, ceftazidime, aminoglycosides, piperacillin/tazobactam and fluoroquinolones (2006–2020), and the reported AMR in Pseudomonas aeruginosa (2013–2020) in Serbia and to compare with data from eight European countries (2015–2020). Method Joinpoint regression was used to analyse antibiotic utilization data (2006–2020) and the reported AMR in Pseudomonas aeruginosa (2013–2020). Data sources were relevant national and international institutions. Antibiotic utilization and AMR in Pseudomonas aeruginosa data in Serbia were compared with eight European countries. Results There was a significantly increased trend for ceftazidime utilization and reported resistance in Pseudomonas aeruginosa, Serbia (p < 0.05) (2018–2020). For ceftazidime, piperacillin/tazobactam, and fluoroquinolones resistances in Pseudomonas aeruginosa an increased trend was observed, Serbia (2013–2020). A decrease in both the utilization of aminoglycosides, Serbia (p < 0.05) (2006–2018) and contemporaneous Pseudomonas aeruginosa resistance (p > 0.05) was detected. Fluoroquinolone utilization (2015–2020) was highest in Serbia compared to Netherlands and Finland, 310 and 305% higher, similar compared to Romania, and 2% less compared to Montenegro. Aminoglycosides (2015–2020) were 2550 and 783% more used in Serbia compared to Finland and Netherlands, and 38% less regarding Montenegro. The highest percentage of Pseudomonas aeruginosa resistance was in Romania and Serbia (2015–2020). Conclusion The use of piperacillin/tazobactam, ceftazidime and fluoroquinolones should be carefully monitored in clinical practice due to increased Pseudomonas aeruginosa resistance. The level of utilization and AMR in Pseudomonas aeruginosa is still high in Serbia compared to other European countries.
- 1 February 2019
- Published by Elsevier in Cancer Epidemiology
- Vol. 58, 52-62
Non-aspirin non-steroidal anti-inflammatory drugs in prevention of colorectal cancer in people aged 40 or older: A systematic review and meta-analysis
- 1 February 2019
- Published by Elsevier in Cancer Epidemiology
- Vol. 58, 52-62
Non-aspirin non-steroidal anti-inflammatory drugs in prevention of colorectal cancer in people aged 40 or older: A systematic review and meta-analysis